Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Schacker

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid TissuesMeghan Rothenberger, Krystelle Nganou-Makamdop, Cissy Kityo, et al.
The Journal of Infectious Diseases|March 11, 2022
Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of InfectionEugène Kroon, Suthat Chottanapund, Supranee Buranapraditkun, et al.
JCI Insight|June 5, 2025
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIVJoshua Rhein, Jeffrey G Chipman, Gregory J Beilman, et al.
Blood|March 4, 2017
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β productionJing Du, Katelyn Paz, Ryan Flynn, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruptionMeghan K Rothenberger, Brandon F Keele, Stephen W Wietgrefe, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
JAMA Network Open|March 16, 2022
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical TrialMichael A Puskarich, Nicholas E Ingraham, Lisa H Merck, et al.
The Journal of Infectious Diseases|May 13, 2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapyElizabeth Nies-Kraske, Timothy W Schacker, David Condoluci, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Plos Medicine|November 29, 2017
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W Cummins, Stacey Rizza, Mark R Litzow, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid TissuesMeghan Rothenberger, Krystelle Nganou-Makamdop, Cissy Kityo, et al.
The Journal of Infectious Diseases|March 11, 2022
Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of InfectionEugène Kroon, Suthat Chottanapund, Supranee Buranapraditkun, et al.
JCI Insight|June 5, 2025
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIVJoshua Rhein, Jeffrey G Chipman, Gregory J Beilman, et al.
Blood|March 4, 2017
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β productionJing Du, Katelyn Paz, Ryan Flynn, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruptionMeghan K Rothenberger, Brandon F Keele, Stephen W Wietgrefe, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
JAMA Network Open|March 16, 2022
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical TrialMichael A Puskarich, Nicholas E Ingraham, Lisa H Merck, et al.
The Journal of Infectious Diseases|May 13, 2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapyElizabeth Nies-Kraske, Timothy W Schacker, David Condoluci, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Plos Medicine|November 29, 2017
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W Cummins, Stacey Rizza, Mark R Litzow, et al.
Pageof 9